BFRG
What one share of Bullfrog Ai Holdings holds
Pharmaceutical Preparations
III oncology company focused on novel chemotherapeutic treatments for rare cancers. Through this collaboration, we will apply our proprietary
Bullfrog Ai Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$0.45 |
| Cash and investments | $0.37 |
| Book value | $0.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$0.14 | — | −$0.09 | — | −$0.22 |
| 2022 | $0.00 | −$0.70 | $0.00 | −$0.23 | — | −$0.76 |
| 2023 | $0.01 | −$0.89 | — | −$0.99 | — | $0.43 |
| 2024 | — | −$0.85 | — | −$0.68 | — | $0.54 |
| 2025 | $0.01 | −$0.63 | — | −$0.53 | — | $0.19 |